Clik here to view.
武田公布2018财年第三季度业绩
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TOKYO:4502, NYSE:TAK)： 本年至今基础营收增长+4.8%，处方药产品组合在各个地区均有增长 基础营收稳步增长+4.8%，武田的增长引擎（胃肠药、肿瘤药、神经科药物和新兴市场）维持了强劲势头 ，增长+10.5%。 主要增长产品Entyvio...
View ArticleClik here to view.
武田在EAHAD 2019上发布同类首创PK指导下预防性治疗IIIb/IV期PROPEL随机试验结果，该试验评估血友病A的较高第VIII因子水平
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 罕见病领域的全球性生物技术领先者武田药品工业株式会社(TSE:4502/NYSE:TAK)（“武田”）今天在欧洲血友病及相关疾病学会(EAHAD)第12届年会上发布了ADYNOVATE...
View ArticleClik here to view.
H.I.G.Capital完成对Taconic Biosciences的收购
波士顿 –(美国商业资讯)–旗下管理着300亿美元股权资本的领先全球私募股权投资公司H.I.G.Capital (“H.I.G.”)欣然宣布，其附属公司之一已与Taconic Biosciences, Inc.（“Taconic”或“该公司”）管理团队合作支持该公司成长为制药、生物科技、合同研究组织(CRO)和学术研究行业领先的全球研究模型和服务提供商。...
View ArticleClik here to view.
キャピタルがタコニック・バイオサイエンシズの買収を完了
ボストン — （ビジネスワイヤ） — 運用資産300億ドルの世界的に有力なプライベート・エクイティ投資会社のHIGキャピタルは、当社投資先企業の1つがタコニック・バイオサイエンシズ（「タコニック」または「同社」）の経営陣と提携したことを発表します。製薬、バイオテクノロジー、CRO、学術研究機関に研究用のモデルとサービスを提供する世界一流企業としての同社の成長を支えることが目的です。...
View ArticleClik here to view.
Samsung Bioepis与C-Bridge Capital联手在中国开展下一代生物类似物的开发和商业化
韩国仁川 (美国商业资讯) — Samsung Bioepis Co., Ltd.今天宣布，通过与C-Bridge Capital的一份授权协议在中国大陆扩大经营。该协议涵盖来自Samsung Bioepis的多个候选生物类似物，包括第三波候选生物类似物SB11和SB12，商品名分别为LUCENTIS® (ranibizumab)和SOLIRIS®...
View ArticleClik here to view.
GI Dynamics Announces Institutional Review Board Approval for EndoBarrier...
BOSTON & SYDNEY GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that it has received...
View ArticleClik here to view.
欧盟委员会核准ADCETRIS® (brentuximab vedotin)联合AVD用于既往未曾治疗的CD30+...
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TSE:4502/NYSE:TAK)今天宣布，欧盟委员会(EC)扩大了ADCETRIS (brentuximab vedotin)现有的上市许可，纳入联合AVD（阿霉素、长春碱、达卡巴嗪）治疗既往未曾治疗的CD30+...
View ArticleClik here to view.
SpeeDx开发呼吸道病毒复合检测
悉尼 (美国商业资讯)– SpeeDx Pty. Ltd.今天宣布向治疗用品管理局(TGA)报批PlexPCR® RespiVirus检测。公司预计将在澳大利亚2019年流感季节前获批。该检测采用SpeeDx市场领先的PlexPCR®复合技术，旨在检测代表10种病毒性呼吸道致病性病原体的14个靶点。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Positive Phase 3 Study for Tezacaftor/Ivacaftor Combination in Children Aged...
BOSTON Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the results of a Phase 3 study conducted in Europe and Australia of tezacaftor in combination with ivacaftor in children...
View ArticleClik here to view.
欧州委員会、未治療のCD30陽性ステージ4ホジキンリンパ腫成人患者に対する数十年ぶりの新規治療法となるアドセトリス（ブレンツキシマブ・ベドチン）とAVDの...
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
Clik here to view.
Further Data Analysis of Bionomics’ Phase 2 Post Traumatic Stress Disorder...
ADELAIDE, Australia Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a global, clinical stage biopharmaceutical company, announces that an additional data analysis conducted in Sweden by Pharmetheus AB...
View ArticleClik here to view.
Shinkowa Pharmaceutical Co., Ltd. Receives an Interim Report of Clinical...
TOKYO Shinkowa Pharmaceutical Co., Ltd. (main office: Chuo-ku, Tokyo, Japan; CEO: Megumi Tanaka) has confirmed for the first time in the world, thanks to the interim report of clinical research on...
View ArticleClik here to view.
Owlstone Medical 与上海交通大学医学院附属仁济医院 率先在中国进行肺癌呼吸活检临床测试
英国剑桥和中国上海同步发布 Owlstone Medical 有限公司是全球医疗诊断公司，开发用于早期疾病检测和精准医学应用的呼气活检器。 Owlstone Medical 与上海交通大学医学院附属仁济医院（下称仁济医院），今日宣布在中国 联合开展肺癌早期检测的临床试验，项目获得李嘉诚基金会的支持。 有见肺癌在中国的病发率不断上升，Owlstone...
View ArticleClik here to view.
Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath...
CAMBRIDGE, England & SHANGHAI, China Owlstone Medical Ltd., a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji...
View ArticleClik here to view.
BIO Announces Partnership with Taiwan BIO for 2019 Conference and Exhibition
WASHINGTON The Biotechnology Innovation Organization (BIO) announced today it will join the Taiwan Bio-Industry Organization (Taiwan BIO) to host BIO Asia-Taiwan from July 24-28 in Taipei, Taiwan....
View ArticleClik here to view.
CHA Health Systems Subsidiary to Form the Largest Healthcare Network to...
LOS ANGELES CHA Health Systems (CHS), a global leader in bio-technology and healthcare, announced that its international subsidiary, CHA Healthcare Singapore Pte. Ltd. (CSG), became the largest...
View ArticleClik here to view.
Gain...
スイス・ルガーノ （ビジネスワイヤ） — GT Gain Therapeutics SAは本日、250万ユーロのシリーズA資金調達を完了したと発表しました。投資企業は、VitaTech S.A.（110万ユーロ）、Helsinn Investment Fund S.A.（100万ユーロ）、既存投資企業のTiVenture S.A.（40万ユーロ）です。 Gain Therapeutics...
View ArticleClik here to view.
Furukawa Electric Launches Single Cell Hunter for Functional Identification...
TOKYO Furukawa Electric (TOKYO:5801)(ISIN:JP3827200001) announced the launch of the Single Cell Hunter, a microchip-based automated live cell high-throughput screening system today. The breakthrough...
View ArticleClik here to view.
LMD’s Smartphone-Integrated e-Checkup™ System Makes Medically-Accurate...
LAUSANNE, Switzerland Leman Micro Devices (LMD), the developer of regulated consumer healthcare products that is backed by major players within the mobile device industry, has announced that...
View Article